[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb (BMY) Stock Moves -1.35%: What You Should Know",
    "summary": "In the most recent trading session, Bristol Myers Squibb (BMY) closed at $49.33, indicating a -1.35% shift from the previous trading day.",
    "url": "https://finnhub.io/api/news?id=5aae8f1bce650dce787e42980e109b1447431105e2324c4aef1410bc0ac80bbe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744839916,
      "headline": "Bristol Myers Squibb (BMY) Stock Moves -1.35%: What You Should Know",
      "id": 133942670,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "In the most recent trading session, Bristol Myers Squibb (BMY) closed at $49.33, indicating a -1.35% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=5aae8f1bce650dce787e42980e109b1447431105e2324c4aef1410bc0ac80bbe"
    }
  },
  {
    "ts": null,
    "headline": "Is Bristol-Myers Squibb Company (BMY) The Dirt Cheap Stock To Invest In Now?",
    "summary": "We recently published a list of 10 Dirt Cheap Stocks To Invest In Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other dirt cheap stocks to invest in now. Investor’s Guide to Navigating the Volatilitc The stock market has been experiencing volatility and has […]",
    "url": "https://finnhub.io/api/news?id=173f8fc0768431f80a990ecec14933a4f3f60dcb38e4a2982b2a500a1f2d1e89",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744838680,
      "headline": "Is Bristol-Myers Squibb Company (BMY) The Dirt Cheap Stock To Invest In Now?",
      "id": 133942671,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Dirt Cheap Stocks To Invest In Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other dirt cheap stocks to invest in now. Investor’s Guide to Navigating the Volatilitc The stock market has been experiencing volatility and has […]",
      "url": "https://finnhub.io/api/news?id=173f8fc0768431f80a990ecec14933a4f3f60dcb38e4a2982b2a500a1f2d1e89"
    }
  },
  {
    "ts": null,
    "headline": "Neurocrine Biosciences: Recent Selloff Has Created A Potential Buying Opportunity",
    "summary": "Neurocrine Biosciences: Recent Selloff Has Created A Potential Buying Opportunity",
    "url": "https://finnhub.io/api/news?id=7a543421532715472fe76ab340824534055f07bbab4dc5aca600ad311e8b8262",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744825893,
      "headline": "Neurocrine Biosciences: Recent Selloff Has Created A Potential Buying Opportunity",
      "id": 133937743,
      "image": "",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=7a543421532715472fe76ab340824534055f07bbab4dc5aca600ad311e8b8262"
    }
  },
  {
    "ts": null,
    "headline": "Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News",
    "summary": "BMY and VERV are in the spotlight this week following the failure of a late-stage study and positive cholesterol study data, respectively.",
    "url": "https://finnhub.io/api/news?id=80e2b62ac7982b3400700384b545db57a1e6148db7a0dc1bfbb71989603ac53c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744823220,
      "headline": "Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News",
      "id": 133941527,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "BMY and VERV are in the spotlight this week following the failure of a late-stage study and positive cholesterol study data, respectively.",
      "url": "https://finnhub.io/api/news?id=80e2b62ac7982b3400700384b545db57a1e6148db7a0dc1bfbb71989603ac53c"
    }
  },
  {
    "ts": null,
    "headline": "Gilead vs Bristol Myers: Which Biotech Bigwig is a Better Bet Now?",
    "summary": "At current levels, we believe GILD scores above BMY, buoyed by solid fundamentals, potential approval of lenacapavir for HIV prevention, and recent positive estimate revisions.",
    "url": "https://finnhub.io/api/news?id=d56e11278c5896d810bf4f8e4e2ed3a5532c24606bbc5f9e9bc98a8fe65a8039",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744823100,
      "headline": "Gilead vs Bristol Myers: Which Biotech Bigwig is a Better Bet Now?",
      "id": 133942630,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "At current levels, we believe GILD scores above BMY, buoyed by solid fundamentals, potential approval of lenacapavir for HIV prevention, and recent positive estimate revisions.",
      "url": "https://finnhub.io/api/news?id=d56e11278c5896d810bf4f8e4e2ed3a5532c24606bbc5f9e9bc98a8fe65a8039"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
    "summary": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=16a40c7c881a4c89e9eb9cd679a3e2c96d88dc4130e042789e7b99cba3533753",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744821480,
      "headline": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
      "id": 133948762,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=16a40c7c881a4c89e9eb9cd679a3e2c96d88dc4130e042789e7b99cba3533753"
    }
  }
]